AKT2	NN
Regulates	VBZ
Pulmonary	JJ
Inflammation	NN
and	CC
Fibrosis	NN
via	IN
Modulating	VBG
Macrophage	NN
Activation	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
highly	RB
lethal	JJ
pathological	JJ
process	NN
that	WDT
is	VBZ
characterized	VBN
by	IN
inflammation	NN
,	,
fibroblast	NN
accumulation	NN
,	,
and	CC
excessive	JJ
collagen	NN
deposition	NN
.	.

Although	IN
AKT2-mediated	JJ
signaling	NN
pathways	NNS
modulate	VBP
inflammatory	JJ
responses	NNS
,	,
their	PRP$
role	NN
in	IN
IPF	NNP
has	VBZ
not	RB
been	VBN
defined	VBN
.	.

We	PRP
report	VBP
that	IN
AKT2	NN
deficiency	NN
(	(
Akt2	NN
-	:
/	:
-	:
)	)
protected	VBN
against	IN
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
and	CC
inflammation	NN
.	.

Adoptive	JJ
transfer	NN
of	IN
wild-type	JJ
macrophages	NNS
or	CC
administration	NN
of	IN
IL-13	NN
to	TO
Akt2	NN
-	:
/	:
-	:
mice	NNS
could	MD
restore	VB
pulmonary	JJ
fibrosis	NN
.	.

In	IN
response	NN
to	TO
IL-33	NN
treatment	NN
,	,
Akt2	NN
-	:
/	:
-	:
macrophages	NNS
displayed	VBD
decreased	VBN
production	NN
of	IN
IL-13	NN
and	CC
TGF-b1	NN
and	CC
attenuated	VBD
phosphorylation	NN
of	IN
FoxO3a	NN
compared	VBN
with	IN
Akt2	NN
+	CC
/	:
+	CC
macrophages	NNS
.	.

Furthermore	RB
,	,
the	DT
expression	NN
of	IN
IL-13	NN
was	VBD
increased	VBN
by	IN
small	JJ
interfering	VBG
RNA	NN
knockdown	NN
of	IN
FoxO3a	NN
or	CC
in	IN
FoxO3a-deficient	JJ
macrophages	NNS
.	.

By	IN
evaluating	VBG
lung	NN
sections	NNS
from	IN
pulmonary	JJ
fibrosis	NN
patients	NNS
,	,
we	PRP
found	VBD
that	IN
the	DT
phosphorylation	NN
of	IN
AKT2	NN
and	CC
FoxO3a	NN
was	VBD
remarkably	RB
upregulated	VBN
.	.

Collectively	RB
,	,
these	DT
results	NNS
indicate	VBP
that	IN
AKT2	NN
modulates	VBZ
pulmonary	JJ
fibrosis	NN
through	IN
inducing	VBG
TGF-b1	NN
and	CC
IL-13	NN
production	NN
by	IN
macrophages	NNS
,	,
and	CC
inhibition	NN
of	IN
AKT2	NN
may	MD
be	VB
a	DT
potential	JJ
strategy	NN
for	IN
treating	VBG
IPF	NN
.	.

